TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 37 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q3 2016. The put-call ratio across all filers is 16.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $34,000 | -35.8% | 73,500 | -2.6% | 0.00% | -50.0% |
| Q3 2016 | $53,000 | -41.8% | 75,500 | +65.9% | 0.00% | -33.3% |
| Q2 2016 | $91,000 | +15.2% | 45,500 | +38.7% | 0.00% | +50.0% |
| Q1 2016 | $79,000 | -66.7% | 32,800 | +6.5% | 0.00% | -71.4% |
| Q4 2015 | $237,000 | +119.4% | 30,800 | +51.7% | 0.01% | +133.3% |
| Q3 2015 | $108,000 | – | 20,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 370,000 | $1,602,000 | 0.67% |